Gary Raskob BS, MS, PhD
Epidemiology, Public Health, Clinical Pharmacology
Connect with the speaker?
Dr. Gary Raskob is the Interim Senior Vice President and Provost at the University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, with overall responsibility for the educational and research programs of its seven colleges, the Stephenson Cancer Center and the Harold Hamm Diabetes Center. He also serves on the Boards of the OU Health System and the University Hospitals Authority and Trust.
Dr. Raskob has academic appointments in the College of Public Health, and the College of Medicine, as a Regents Professor of Epidemiology and Medicine. He began his career at the OU Health Sciences Center in 1991. His research and scholarly interests are in the prevention and treatment of deep-vein thrombosis and pulmonary embolism; clinical trials and antithrombotic drug development; evidence-based medicine and public health; and the translation of research evidence into practice.
Dr. Raskob has participated extensively in clinical practice guideline development for several specialty organizations including the American Society of Hematology (ASH), the American College of Chest Physicians (ACCP), the American Thoracic Society (ATS), and the American Society of Clinical Oncology (ASCO). He also served as a member of the external advisory panel on thrombosis and hemostasis for the National Heart, Lung, and Blood Institute (NHLBI), and as an advisor on blood disorders to the Centers for Disease Control and Prevention (CDC). He was the inaugural Chair of the Steering Committee for the World Thrombosis Day initiative of the International Society in Thrombosis and Haemostasis (ISTH), from 2013 through 2019, and he currently serves on the Board of Directors for the National Blood Clot Alliance (NBCA), the major patient advocacy organization in the United States for patients with venous thrombosis and pulmonary embolism. He is the author or co-author of more than 200 publications on the prevention, diagnosis, and treatment of thromboembolic disease, including 21 articles in the New England Journal of Medicine.
Dr. Raskob has academic appointments in the College of Public Health, and the College of Medicine, as a Regents Professor of Epidemiology and Medicine. He began his career at the OU Health Sciences Center in 1991. His research and scholarly interests are in the prevention and treatment of deep-vein thrombosis and pulmonary embolism; clinical trials and antithrombotic drug development; evidence-based medicine and public health; and the translation of research evidence into practice.
Dr. Raskob has participated extensively in clinical practice guideline development for several specialty organizations including the American Society of Hematology (ASH), the American College of Chest Physicians (ACCP), the American Thoracic Society (ATS), and the American Society of Clinical Oncology (ASCO). He also served as a member of the external advisory panel on thrombosis and hemostasis for the National Heart, Lung, and Blood Institute (NHLBI), and as an advisor on blood disorders to the Centers for Disease Control and Prevention (CDC). He was the inaugural Chair of the Steering Committee for the World Thrombosis Day initiative of the International Society in Thrombosis and Haemostasis (ISTH), from 2013 through 2019, and he currently serves on the Board of Directors for the National Blood Clot Alliance (NBCA), the major patient advocacy organization in the United States for patients with venous thrombosis and pulmonary embolism. He is the author or co-author of more than 200 publications on the prevention, diagnosis, and treatment of thromboembolic disease, including 21 articles in the New England Journal of Medicine.
Quick Links
Connect With Us
Awards & Recognitions
- 50 Division Street, Suite 501,
- Somerville, NJ 08876
- support@emedevents.com